Tempest Therapeutics, Inc. Shareholders' Equity
Tempest Therapeutics, Inc. (TPST) had Shareholders' Equity of -$1.09 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$1.09M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $822.00K.
- 2025-12-31: Stockholders' Equity Attributable to Parent $6.67M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.35M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$1.09M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $822.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $6.67M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $6.35M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $9.78M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $11.13M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $19.13M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $11.46M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $16.94M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $20.63M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $26.77M 10-K · filed 2026-03-30 | |
| 2023-09-30 | -$1.19M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $5.01M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $10.96M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $18.11M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $26.77M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $34.93M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $29.36M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $36.12M 10-K · filed 2024-03-19 | |
| 2021-09-30 | -$43.54M 10-Q · filed 2022-11-08 | $43.54M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $48.11M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | -$73.95M 10-Q · filed 2022-11-08 | $24.96M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$68.79M 10-K · filed 2023-03-22 | $33.06M 10-K · filed 2021-03-29 |
| 2020-09-30 | -$64.65M 10-Q · filed 2021-11-10 | $39.15M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$59.37M 10-Q · filed 2021-11-10 | $44.28M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$54.47M 10-Q · filed 2021-08-12 | $53.83M 10-Q · filed 2020-05-08 |
| 2019-12-31 | -$50.36M 10-K · filed 2022-03-29 | $58.55M 10-K · filed 2020-03-11 |
| 2019-09-30 | $43.07M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $52.97M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $61.52M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $70.95M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $44.91M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $50.21M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $57.33M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | -$130.69M 10-K · filed 2019-04-01 | $64.30M 10-K · filed 2018-03-15 |
| 2017-09-30 | $72.29M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $81.14M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $94.72M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $108.22M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $129.88M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $146.56M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $108.84M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $126.85M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $142.59M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $156.71M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $169.09M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $55.33M 10-K · filed 2018-03-15 | |
| 2014-09-30 | $68.63M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $78.70M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $86.40M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $41.70M 10-K · filed 2017-03-02 | |
| 2013-09-30 | $49.00M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $54.41M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $59.06M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $30.72M 10-K · filed 2016-02-26 | |
| 2012-09-30 | $34.41M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$8.02M 10-Q · filed 2012-08-14 | |
| 2011-12-31 | -$2.38M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |